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To control the growth of microorganisms on its surface, human skin produces and releases
certain peptides and proteins, including cathelicidin LL-37 and β-defensins. The ribonuclease
A (RNase A) superfamily is an important class in this armament (Koczera et al., 2016). This
superfamily consists of 13 genes located on chromosome 14; eight of the 13 genes encode proteins
(RNases 1–8) that are catalytically active on RNA substrates (Abtin et al., 2009; Simanski et al., 2012;
Prats-Ejarque et al., 2016; Pulido et al., 2016).
Among the eight catalytically active RNases in the RNase A superfamily, only RNases 1, 4,
5, and 7 are expressed in human keratinocytes (Abtin et al., 2009; Simanski et al., 2012). The
expression level of RNase 7 is the highest among these four RNases, and only RNases 5 and 7 exhibit
antibacterial activity in vitro. The bactericidal action of RNase 7 is based on its binding to and
destabilization of the bacterial membrane by way of an electrostatically driven protein-membrane
association followed by the formation of transient “holes” on the destabilized membrane, causing
the leakage/release of the inner contents (Torrent et al., 2009). RNase 7 exhibits a broad-spectrum
activity against a variety of Gram-positive and Gram-negative bacteria including Staphylococcus
aureus, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, and
Proteus mirabilis (Pulido et al., 2013; Wang, 2014; Rademacher et al., 2016, 2017). This bactericidal
activity is independent of its ribonucleolytic activity (Simanski et al., 2012).
The antimicrobial activity of RNase 5 has been observed against the Gram-positive bacterium
Streptococcus pneumoniae and the yeast Candida albicans (Hooper et al., 2003). Abtin et al. found
that the antifungal activity of RNase 5 against C. albicans requires its ribonucleolytic activity (Abtin
et al., 2009; Zasloff, 2009). It is not currently known whether its antibacterial activity against S.
pneumoniae requires the same prerequisite/co-requisite.
In addition to their antipathogenic activity, the ribonucleolytic activity of RNases on human
skin has been investigated. Steve Pascolo’s research group discovered that naturally-occurring
RNase activity on the surface of human skin specifically targets cytosine (C) residues (Probst et al.,
2006). They tested synthetic single-stranded RNA homopolymers 18 nucleotides in length, and
determined that while poly(A), poly(G), and poly(U) oligonucleotides remain intact in the presence
of human skin RNases, poly(C) oligonucleotides are degraded (Probst et al., 2006).
Other human skin proteins also display ribonuclease activity. Miriam Brysk’s research group
reported that desquamins, glycoproteins not belonging to the RNase A superfamily, have
demonstrated both RNase and protease activity (Selvanayagam et al., 1998). Desquamins are
expressed in the transition zone between the granular layer and the stratum corneum. Functioning
as RNases, desquamins have been found to degrade only poly(C) RNA; homopolymers of A, U, and
G are not affected (Selvanayagam et al., 1998).
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The author experimentally investigates RNA structure, and
has found that even with the strictest precautions during
experimental procedures, RNA transcripts are occasionally cut
at C residues, leading to the conclusion that human skin is
the only remaining probable source of RNase contamination.
Based on existing and/or predicted RNA structural information,
the cleavage at C nucleotides always occurs in single-stranded
portions of their RNA molecules (Wang et al., 2008).
The GC content in bacteria varies widely, from approximately
14 to 75% (Agashe and Shankar, 2014). Why do the RNases
on the surface of human skin specifically cleave single-stranded
C nucleotides of RNA? The author proposes that the target
specificity of human skin RNases may be due to certain
characteristic C-rich motif(s) widely distributed within bacterial
genomes. Current knowledge suggests that an unstructured
C-rich motif is widespread among bacterial RNAs: the Rho-
dependent transcription terminators, which consist of single-
stranded C-rich sequences, known as a Rho utilization site (rut),
in the nascent RNA. Once bound to the rut site in a newly
transcribed RNA, the ATPase activity of Rho is activated, driving
its translocation down the RNA. Rho then catches up with
the RNA polymerase; the interaction between the Rho protein
and the RNA polymerase complex stimulates the dissociation
of the transcriptional complex, which results in the termination
of transcription. While rut sites are C-rich, a clear consensus
sequence has not been identified (Peters et al., 2009).
Rho-dependent termination accounts for up to half of all
transcription termination events in bacteria. Rho-dependent
terminators are located at the 3′ ends of genes (intergenic), within
the coding sequences of genes (intragenic), and even in the 5′
leader regions (to regulate transcriptional elongation of specific
genes into their respective downstream coding regions) (Peters
et al., 2009; Hollands et al., 2012, 2014). The author hypothesizes
that these widely distributed rut sites (i.e., unstructured C-rich
sequences) may be the reason that targeting the single-stranded
poly(C) region of bacterial RNA is enough for human skin
RNases to succeed against bacterial invasion. Once the skin
RNase cleaves the rut site in a nascent bacterial RNA, the Rho
protein can no longer bind to the RNA, and thus will not interact
with the RNA polymerase to properly terminate transcription.
The author believes she is the first to present the hypothesis that
the targeting specificity of human skin RNases may be due to the
widely-distributed unstructured C-rich motifs in bacteria, since
no related publications have been found to date.
The author proposes that human skin RNases provide dual
protection against invading bacteria: They may bind to and
disrupt bacterial membranes, and/or may enter bacteria and
disrupt their transcription process (see Figure 1). Human skin
RNase 7 may be an important defense mechanism against
microorganisms that do not use Rho-dependent transcriptional
terminators (i.e., their RNAs may not have an unstructured C-
rich region), as it can rapidly inactivate these organisms through
membrane disruption. For microorganisms that do use Rho-
dependent transcriptional terminators, the mechanism(s) by
which RNases on human skin gain entrance into the bacterial
cell to exert their ribonuclease activity is currently unknown.
The author hypothesizes that the RNases may bind to a specific
FIGURE 1 | A simplified schematic representation of the two
mechanisms human skin RNases may employ against invading
bacteria. These RNases may bind to and disrupt bacterial membranes,
and/or may enter the bacteria and disrupt their transcription process by
cleaving the rut site (unstructured C-rich sequences) in nascent bacterial RNA.
lipoprotein associated with the bacterial membrane leading to the
processing and internalization of the membrane protein along
with the skin RNases.
It is known that several members of both the RNase A
superfamily (RNases 1, 4, 5, and 7) and the desquamin class
of RNases are expressed in human skin, and that human skin
RNases as a whole specifically cleave RNA substrates at single-
stranded C-rich regions (Probst et al., 2006; Zasloff, 2009).
Among these RNases, RNases 5 and 7 (especially RNase 7) have
demonstrated their ability against a variety of microorganisms
(Hooper et al., 2003; Pulido et al., 2013; Rademacher et al.,
2016, 2017). Useful insights on the mechanisms of cutaneous
defenses against invading bacteria would be gained from
studies focused on the determination of the ribonucleolytic
activity of each of the above-mentioned RNases individually.
In addition, a comparison of their relative activity would allow
the identification of the major contributor to the cleavage of
bacterial RNA found on human skin. Furthermore, there may be
other proteins on the human epidermis that demonstrate a C-
cleaving ribonuclease activity. Research to isolate such RNases
and determine their function and activity would contribute
to a more complete view of the host-defense system of
human skin.
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